Optimizerx Corporation (OPRX) 1.6800 $OPRX
OPTIMIZERx Targets Animal Health Market to Provide Automated Savings Through Veterinary Practices
Marketwire - Wed Apr 09, 8:17AM CDT
OPTIMIZERx Corporation (OTCQB: OPRX) announced today it has launched VoucherDVM(TM) to assist veterinarians in providing automated savings on the products and medications prescribed to their customers.
OPTIMIZERx Corporation Announces 2013 Year End Results
Marketwire - Mon Mar 31, 11:05AM CDT
OPTIMIZERx Corp. (OTCQB: OPRX) announced fourth quarter revenues of $1,810,610, bringing total revenues for fiscal 2013 to $4,957,016 -- an increase of 149% over 2012. OPTIMIZERx Corp. also achieved net income of $215,847 for the year after recognizing a onetime adjustment relative to our cost of goods sold which reflects a change in accounting procedures for reporting revenue share expenses.
Merriman Capital Serves as Sole Manager of OptimizeRx's $10 Million Private Offering
Thomson Reuters ONE - Mon Mar 24, 8:00AM CDT
SAN FRANCISCO, March 24, 2014 - Merriman Capital, Inc., a wholly owned subsidiary of Merriman Holdings, Inc. (OTCQX: MERR) announced today that it acted as sole manager of the $10 million equity offering for OptimizeRx Corporation (OTCQB: OPRX).
OPTIMIZERx Announces Sponsorship of the CBInet eRx and EHR Conference
Marketwire - Thu Mar 20, 1:46PM CDT
OPTIMIZERx Corp (OTCQB: OPRX) today announced that it is sponsoring the CBInet eRx and EHR conference March 26 - 27 in Philadelphia, PA.
OptimizeRx Completes Capital Raise to Exercise Securities Redemption Option Agreement With Vicis
Marketwire - Tue Mar 18, 8:33AM CDT
OptimizeRx Corporation (OTCQB: OPRX) announced today it has completed its capital raise of $10 Million and will be exercising the buyout option with Vicis Capital Master Fund to redeem all securities it holds in the Company. This includes all the Series A Convertible Preferred Stock, Series B Convertible Preferred Stock, common stock, and all derivative securities, which includes the Series A Warrant to Purchase Common Stock and Series B Warrant to Purchase Common Stock held by Vicis. With these holdings redeemed, we will no longer owe any dividend obligations to Vicis.
OPTIMIZERx Announces Accounting Change
Marketwire - Wed Feb 05, 10:07AM CST
OPTIMIZERx Corp (OTCQB: OPRX) announced its accounting and audit firm has determined a needed adjustment to the accounting policy so that the revenue share expenses are properly accrued each quarter and at the end of the year, versus when they are paid. The method of recording revenue share payments previously aligned with our contractual terms with our platform partners -- which generally required payment 30 days after we received the fees from our sponsored manufacturers in the following quarter. Therefore, for year-end 2012 and each quarter of 2013, there will be a journal entry needed to record the revenue share amounts due on an accrual basis rather than recording these as an expense when they are paid.
OPTIMIZERx Announces Record Preliminary 2013 4th Quarter Results and Update
Marketwire - Wed Jan 22, 6:30AM CST
OPTIMIZERx Corp (OTCQB: OPRX) today announced preliminary 2013 fourth quarter results.
OPTIMIZERx Corporation to Present at Noble Financial Capital Markets' Tenth Annual Equity Conference
Marketwire - Thu Jan 16, 10:31AM CST
OPTIMIZERx Corporation (OTCQB: OPRX) today announced that its Chairman and CEO Mr. David Harrell will present at "TEN"; Noble Financial Capital Markets' Tenth Annual Equity Conference at Club Med in Sandpiper Bay, Florida, on Monday January 20, 2014 at 9:30 AM Eastern Time.
Renamo Gunmen Strike in Funhaloro
All Africa Global Media - Tue Jan 14, 12:39PM CST
Gunmen of the former rebel movement Renamo killed at least one person in an attack in the early hours of Tuesday morning against Mavume locality, in the southern province of Inhambane, according to a report on Radio Mozambique.
OPTIMIZERx Corporation Executes New Terms to Securities Redemption Option Agreement With Vicis
Marketwire - Fri Jan 03, 9:10AM CST
OPTIMIZERx Corp. (OTCQB: OPRX) announced on January 2, 2014, we executed an Amendment to the Securities Redemption Option Agreement with Vicis Capital Master Fund ("Vicis"
to, among other things, extend the term of our option to March 31, 2014 and reduce the price of the option from nine million dollars ($9,000,000) to six million dollars ($6,000,000). The shares and derivative securities include the Series A Convertible Preferred Stock, Series B Convertible Preferred Stock, Common Stock, and warrants to purchase shares of Series A Convertible Preferred Stock and Series B Convertible Preferred Stock held by Vicis.
OPTIMIZERx Corporation Q-3 Earnings Call
Marketwire - Thu Nov 14, 10:08AM CST
OPTIMIZERx Corp. (OTCQB: OPRX) will be holding its Q-3 earnings call on Tuesday November 19th at 12:00 PM Eastern Standard Time. The call information for guests is:
OPTIMIZERx Corporation Announces the Resignation of the Company's Current CEO & Chairman Mr. Shadron L. Stastney
PR Newswire - Fri Sep 20, 5:01PM CDT
OPTIMIZERx Corp. (OTCQB: OPRX) today announced that the Company's current Chief Executive Officer, Mr. Shadron L. Stastney, has provided the Board of Directors his resignation for personal reasons. While the Company's Board of Directors has accepted his resignation, effective today, the Company will retain Mr. Stastney's services on a limited basis for advisory work through the end of the year to help the transition with several ongoing projects.
OPTIMIZERx Corporation Announces the Launch of OPTIMIZEHR® to Assist Pharmaceutical Clients with their EHR Strategies & Implementation
PR Newswire - Fri Sep 13, 10:12AM CDT
OPTIMIZERx Corp. (OTCQB: OPRX) today announced the launch of OPTIMIZEHR® the company's Electronic Heath Record (EHR) consulting and implementation practice.
OTC Daily Alert Stock Watch - OPTIMIZERx Corp. (OTCQB: OPRX)
WorldStockWire - Fri Aug 16, 6:30PM CDT
OTC Daily Alert tracks stocks daily and is pleased to offer features on public companies. Investors can receive FREE Stock Alerts and company news and profiles by visiting OTC Daily Alert at the following: http://www.otcdailyalert.com
OPTIMIZERx Corporation Announces Partnership With HealthTronics to Deliver Patient Savings and Support
Marketwire - Tue Jul 30, 7:01AM CDT
OPTIMIZERx Corp. (OTCQB: OPRX) today announced a new alliance, expanding the delivery of its SampleMD solution to an important physician specialty group.
OPTIMIZERx Announces Record Preliminary 2013 Second Quarter Results and Update
Marketwire - Thu Jul 18, 10:54AM CDT
OPTIMIZERx Corp (OTCQB: OPRX) today announced record preliminary 2013 second quarter results.
PDR Network and OPTIMIZERx (SampleMD) Announce Partnership to Deliver Patient Financial Support Programs Within EHR Workflow
PR Newswire - Wed May 29, 1:15PM CDT
PDR Network®, the leading distributor of FDA-approved patient drug safety and support services for electronic health record (EHR) and e-prescribing (e-Rx) platforms, today announced a strategic partnership with OPTIMIZERx Corp. (OTCBB: OPRX), the industry innovator in developing and delivering digital patient financial support technology within the e-prescribing workflow. Under the agreement PDR will bring to market OPTIMIZERx's patent solution for e-Coupons in EHR workflow to the parties' extensive combined EHR network.
OPTIMIZERx Corporation Announces SampleMD(TM) Q1 2013 Operational Update
Marketwire - Tue Apr 16, 9:45AM CDT
Today OPTIMIZERx Corporation (OTCQB: OPRX) announced the preliminary results of SampleMD's eCoupon and eVoucher distributions from January 1st, 2013 through March 28th, 2013. The Company reported that from January 1st, 2013 through March 28th 2013, SampleMD generated over 177,000 new ePrescriptions with Co-Pay Coupons or Free Sample Voucher to help patients more affordably start and stay on their prescribed medications.
OPTIMIZERx Targets Animal Health Market to Provide Automated Savings Through Veterinary Practices
Marketwire - Wed Apr 09, 8:17AM CDT
OPTIMIZERx Corporation (OTCQB: OPRX) announced today it has launched VoucherDVM(TM) to assist veterinarians in providing automated savings on the products and medications prescribed to their customers.
OPTIMIZERx Corporation Announces 2013 Year End Results
Marketwire - Mon Mar 31, 11:05AM CDT
OPTIMIZERx Corp. (OTCQB: OPRX) announced fourth quarter revenues of $1,810,610, bringing total revenues for fiscal 2013 to $4,957,016 -- an increase of 149% over 2012. OPTIMIZERx Corp. also achieved net income of $215,847 for the year after recognizing a onetime adjustment relative to our cost of goods sold which reflects a change in accounting procedures for reporting revenue share expenses.
Merriman Capital Serves as Sole Manager of OptimizeRx's $10 Million Private Offering
Thomson Reuters ONE - Mon Mar 24, 8:00AM CDT
SAN FRANCISCO, March 24, 2014 - Merriman Capital, Inc., a wholly owned subsidiary of Merriman Holdings, Inc. (OTCQX: MERR) announced today that it acted as sole manager of the $10 million equity offering for OptimizeRx Corporation (OTCQB: OPRX).
OPTIMIZERx Announces Sponsorship of the CBInet eRx and EHR Conference
Marketwire - Thu Mar 20, 1:46PM CDT
OPTIMIZERx Corp (OTCQB: OPRX) today announced that it is sponsoring the CBInet eRx and EHR conference March 26 - 27 in Philadelphia, PA.
OptimizeRx Completes Capital Raise to Exercise Securities Redemption Option Agreement With Vicis
Marketwire - Tue Mar 18, 8:33AM CDT
OptimizeRx Corporation (OTCQB: OPRX) announced today it has completed its capital raise of $10 Million and will be exercising the buyout option with Vicis Capital Master Fund to redeem all securities it holds in the Company. This includes all the Series A Convertible Preferred Stock, Series B Convertible Preferred Stock, common stock, and all derivative securities, which includes the Series A Warrant to Purchase Common Stock and Series B Warrant to Purchase Common Stock held by Vicis. With these holdings redeemed, we will no longer owe any dividend obligations to Vicis.
OPTIMIZERx Announces Accounting Change
Marketwire - Wed Feb 05, 10:07AM CST
OPTIMIZERx Corp (OTCQB: OPRX) announced its accounting and audit firm has determined a needed adjustment to the accounting policy so that the revenue share expenses are properly accrued each quarter and at the end of the year, versus when they are paid. The method of recording revenue share payments previously aligned with our contractual terms with our platform partners -- which generally required payment 30 days after we received the fees from our sponsored manufacturers in the following quarter. Therefore, for year-end 2012 and each quarter of 2013, there will be a journal entry needed to record the revenue share amounts due on an accrual basis rather than recording these as an expense when they are paid.
OPTIMIZERx Announces Record Preliminary 2013 4th Quarter Results and Update
Marketwire - Wed Jan 22, 6:30AM CST
OPTIMIZERx Corp (OTCQB: OPRX) today announced preliminary 2013 fourth quarter results.
OPTIMIZERx Corporation to Present at Noble Financial Capital Markets' Tenth Annual Equity Conference
Marketwire - Thu Jan 16, 10:31AM CST
OPTIMIZERx Corporation (OTCQB: OPRX) today announced that its Chairman and CEO Mr. David Harrell will present at "TEN"; Noble Financial Capital Markets' Tenth Annual Equity Conference at Club Med in Sandpiper Bay, Florida, on Monday January 20, 2014 at 9:30 AM Eastern Time.
Renamo Gunmen Strike in Funhaloro
All Africa Global Media - Tue Jan 14, 12:39PM CST
Gunmen of the former rebel movement Renamo killed at least one person in an attack in the early hours of Tuesday morning against Mavume locality, in the southern province of Inhambane, according to a report on Radio Mozambique.
OPTIMIZERx Corporation Executes New Terms to Securities Redemption Option Agreement With Vicis
Marketwire - Fri Jan 03, 9:10AM CST
OPTIMIZERx Corp. (OTCQB: OPRX) announced on January 2, 2014, we executed an Amendment to the Securities Redemption Option Agreement with Vicis Capital Master Fund ("Vicis"
to, among other things, extend the term of our option to March 31, 2014 and reduce the price of the option from nine million dollars ($9,000,000) to six million dollars ($6,000,000). The shares and derivative securities include the Series A Convertible Preferred Stock, Series B Convertible Preferred Stock, Common Stock, and warrants to purchase shares of Series A Convertible Preferred Stock and Series B Convertible Preferred Stock held by Vicis. OPTIMIZERx Corporation Q-3 Earnings Call
Marketwire - Thu Nov 14, 10:08AM CST
OPTIMIZERx Corp. (OTCQB: OPRX) will be holding its Q-3 earnings call on Tuesday November 19th at 12:00 PM Eastern Standard Time. The call information for guests is:
OPTIMIZERx Corporation Announces the Resignation of the Company's Current CEO & Chairman Mr. Shadron L. Stastney
PR Newswire - Fri Sep 20, 5:01PM CDT
OPTIMIZERx Corp. (OTCQB: OPRX) today announced that the Company's current Chief Executive Officer, Mr. Shadron L. Stastney, has provided the Board of Directors his resignation for personal reasons. While the Company's Board of Directors has accepted his resignation, effective today, the Company will retain Mr. Stastney's services on a limited basis for advisory work through the end of the year to help the transition with several ongoing projects.
OPTIMIZERx Corporation Announces the Launch of OPTIMIZEHR® to Assist Pharmaceutical Clients with their EHR Strategies & Implementation
PR Newswire - Fri Sep 13, 10:12AM CDT
OPTIMIZERx Corp. (OTCQB: OPRX) today announced the launch of OPTIMIZEHR® the company's Electronic Heath Record (EHR) consulting and implementation practice.
OTC Daily Alert Stock Watch - OPTIMIZERx Corp. (OTCQB: OPRX)
WorldStockWire - Fri Aug 16, 6:30PM CDT
OTC Daily Alert tracks stocks daily and is pleased to offer features on public companies. Investors can receive FREE Stock Alerts and company news and profiles by visiting OTC Daily Alert at the following: http://www.otcdailyalert.com
OPTIMIZERx Corporation Announces Partnership With HealthTronics to Deliver Patient Savings and Support
Marketwire - Tue Jul 30, 7:01AM CDT
OPTIMIZERx Corp. (OTCQB: OPRX) today announced a new alliance, expanding the delivery of its SampleMD solution to an important physician specialty group.
OPTIMIZERx Announces Record Preliminary 2013 Second Quarter Results and Update
Marketwire - Thu Jul 18, 10:54AM CDT
OPTIMIZERx Corp (OTCQB: OPRX) today announced record preliminary 2013 second quarter results.
PDR Network and OPTIMIZERx (SampleMD) Announce Partnership to Deliver Patient Financial Support Programs Within EHR Workflow
PR Newswire - Wed May 29, 1:15PM CDT
PDR Network®, the leading distributor of FDA-approved patient drug safety and support services for electronic health record (EHR) and e-prescribing (e-Rx) platforms, today announced a strategic partnership with OPTIMIZERx Corp. (OTCBB: OPRX), the industry innovator in developing and delivering digital patient financial support technology within the e-prescribing workflow. Under the agreement PDR will bring to market OPTIMIZERx's patent solution for e-Coupons in EHR workflow to the parties' extensive combined EHR network.
OPTIMIZERx Corporation Announces SampleMD(TM) Q1 2013 Operational Update
Marketwire - Tue Apr 16, 9:45AM CDT
Today OPTIMIZERx Corporation (OTCQB: OPRX) announced the preliminary results of SampleMD's eCoupon and eVoucher distributions from January 1st, 2013 through March 28th, 2013. The Company reported that from January 1st, 2013 through March 28th 2013, SampleMD generated over 177,000 new ePrescriptions with Co-Pay Coupons or Free Sample Voucher to help patients more affordably start and stay on their prescribed medications.
